Re-Evaluating the Transplant Glomerulopathy Lesion—Beyond Donor-Specific Antibodies
Chutani A, Guevara-Pineda D, Lerner G, Menon M. Re-Evaluating the Transplant Glomerulopathy Lesion—Beyond Donor-Specific Antibodies. Transplant International 2024, 37: 13365. DOI: 10.3389/ti.2024.13365.Peer-Reviewed Original ResearchTransplant glomerulopathyLonger-term graft survivalCell-mediated immune mechanismsChronic allograft damageNon-HLA antibodiesDonor-specific antibodiesAnti-HLA alloantibodiesChronic allograft dysfunctionPathogenesis of transplant glomerulopathyPost-transplant yearComplement-mediated injuryShort-term outcomesAllograft dysfunctionAllograft damageGraft lossGraft survivalRenal transplantationEtiological diagnosisPodocyte stressHistological manifestationsImmune mechanismsMorphological lesionsGlomerulopathyTransplantationReview article